Eton Pharmaceuticals, Inc. (ETON) Operating cash flow 2018–2025
Eton Pharmaceuticals, Inc. (ETON) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$10.5MFY2025 · since FY2018: -$8.1M → $10.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.5M | +986.1% |
| FY2024 | $969,000 | -85.8% |
| FY2023 | $6.8M | +41.4% |
| FY2022 | $4.8M | +202.1% |
| FY2021 | -$4.7M | +78.9% |
| FY2020 | -$22.3M | -24.0% |
| FY2019 | -$18.0M | -121.3% |
| FY2018 | -$8.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ETON financial trends
ETON RevenueETON Net incomeETON Net marginETON Gross profitETON Gross marginETON Operating incomeETON Operating marginETON Free cash flowETON Capital expendituresETON Return on equityETON Stock buybacksETON Dividends paidETON Total assetsETON Total liabilitiesETON Shareholders’ equityETON overview →